226 related articles for article (PubMed ID: 31138163)
21. Adaptable stirred-tank culture strategies for large scale production of multicellular spheroid-based tumor cell models.
Santo VE; Estrada MF; Rebelo SP; Abreu S; Silva I; Pinto C; Veloso SC; Serra AT; Boghaert E; Alves PM; Brito C
J Biotechnol; 2016 Mar; 221():118-29. PubMed ID: 26815388
[TBL] [Abstract][Full Text] [Related]
22. Impact of a Desmoplastic Tumor Microenvironment for Colon Cancer Drug Sensitivity: A Study with 3D Chimeric Tumor Spheroids.
Goudar VS; Koduri MP; Ta YN; Chen Y; Chu LA; Lu LS; Tseng FG
ACS Appl Mater Interfaces; 2021 Oct; 13(41):48478-48491. PubMed ID: 34633791
[TBL] [Abstract][Full Text] [Related]
23. Ready to go 3D? A semi-automated protocol for microwell spheroid arrays to increase scalability and throughput of 3D cell culture testing.
Basu A; Dydowiczová A; Trosko JE; Bláha L; Babica P
Toxicol Mech Methods; 2020 Oct; 30(8):590-604. PubMed ID: 32713235
[TBL] [Abstract][Full Text] [Related]
24. A novel 3D high-content assay identifies compounds that prevent fibroblast invasion into tissue surrogates.
Wenzel C; Otto S; Prechtl S; Parczyk K; Steigemann P
Exp Cell Res; 2015 Nov; 339(1):35-43. PubMed ID: 26475730
[TBL] [Abstract][Full Text] [Related]
25. In Vitro 3D Models of Tunable Stiffness.
Filipe EC; Parker AL; Cadell AL; Major G; Croucher DR; Cox TR
Methods Mol Biol; 2021; 2294():27-42. PubMed ID: 33742392
[TBL] [Abstract][Full Text] [Related]
26. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Johannessen CM; Boehm JS; Kim SY; Thomas SR; Wardwell L; Johnson LA; Emery CM; Stransky N; Cogdill AP; Barretina J; Caponigro G; Hieronymus H; Murray RR; Salehi-Ashtiani K; Hill DE; Vidal M; Zhao JJ; Yang X; Alkan O; Kim S; Harris JL; Wilson CJ; Myer VE; Finan PM; Root DE; Roberts TM; Golub T; Flaherty KT; Dummer R; Weber BL; Sellers WR; Schlegel R; Wargo JA; Hahn WC; Garraway LA
Nature; 2010 Dec; 468(7326):968-72. PubMed ID: 21107320
[TBL] [Abstract][Full Text] [Related]
27. The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression.
Phadke MS; Sini P; Smalley KS
Mol Cancer Ther; 2015 Jun; 14(6):1354-64. PubMed ID: 25873592
[TBL] [Abstract][Full Text] [Related]
28. Characterization of 3D NSCLC Cell Cultures with Fibroblasts or Macrophages for Tumor Microenvironment Studies and Chemotherapy Screening.
Garnique ADMB; Machado-Santelli GM
Cells; 2023 Dec; 12(24):. PubMed ID: 38132110
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic profiling of Raf inhibitors and mitochondrial toxicity in 3D tissue using biodynamic imaging.
An R; Merrill D; Avramova L; Sturgis J; Tsiper M; Robinson JP; Turek J; Nolte DD
J Biomol Screen; 2014 Apr; 19(4):526-37. PubMed ID: 24361645
[TBL] [Abstract][Full Text] [Related]
30. High-throughput CRISPR-mediated 3D enrichment platform for functional interrogation of chemotherapeutic resistance.
Grandhi TSP; To J; Romero A; Luna F; Barnes W; Walker J; Moran R; Newlin R; Miraglia L; Orth AP; Horman SR
Biotechnol Bioeng; 2021 Aug; 118(8):3187-3199. PubMed ID: 34050941
[TBL] [Abstract][Full Text] [Related]
31. Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models.
Hundsberger H; Stierschneider A; Sarne V; Ripper D; Schimon J; Weitzenböck HP; Schild D; Jacobi N; Eger A; Atzler J; Klein CT; Wiesner C
Molecules; 2021 Jan; 26(3):. PubMed ID: 33573155
[TBL] [Abstract][Full Text] [Related]
32. Preparation, Drug Treatment, and Immunohistological Analysis of Tri-Culture Spheroid 3D Melanoma-Like Models.
Schäfer MEA; Klicks J; Hafner M; Rudolf R
Methods Mol Biol; 2021; 2265():173-183. PubMed ID: 33704714
[TBL] [Abstract][Full Text] [Related]
33. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
34. Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype.
Ho AL; Musi E; Ambrosini G; Nair JS; Deraje Vasudeva S; de Stanchina E; Schwartz GK
PLoS One; 2012; 7(7):e40439. PubMed ID: 22808163
[TBL] [Abstract][Full Text] [Related]
35. Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate.
Lee SY; Teng Y; Son M; Ku B; Hwang HJ; Tergaonkar V; Chow PK; Lee DW; Nam DH
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443536
[TBL] [Abstract][Full Text] [Related]
36. Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening.
Griner LM; Gampa K; Do T; Nguyen H; Farley D; Hogan CJ; Auld DS; Silver SJ
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30247463
[TBL] [Abstract][Full Text] [Related]
37. Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment.
Seip K; Jørgensen K; Haselager MV; Albrecht M; Haugen MH; Egeland EV; Lucarelli P; Engebraaten O; Sauter T; Mælandsmo GM; Prasmickaite L
Cancer Lett; 2018 Dec; 439():1-13. PubMed ID: 30240588
[TBL] [Abstract][Full Text] [Related]
38. Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.
Brodaczewska KK; Bielecka ZF; Maliszewska-Olejniczak K; Szczylik C; Porta C; Bartnik E; Czarnecka AM
Oncol Rep; 2019 Nov; 42(5):1878-1892. PubMed ID: 31545459
[TBL] [Abstract][Full Text] [Related]
39. Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models.
Filipiak-Duliban A; Brodaczewska K; Kajdasz A; Kieda C
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163092
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status.
Byron SA; Loch DC; Wellens CL; Wortmann A; Wu J; Wang J; Nomoto K; Pollock PM
Mol Cancer; 2012 Oct; 11():75. PubMed ID: 23039341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
